Benchmark cuts E.W. Scripps stock price target on Q2 headwinds By Investing.com

Benchmark cut its price target on E.W. Scripps to $8 from $10 while keeping a Buy rating, citing continued execution and a transformation plan that could add $125 million to $150 million of EBITDA by 2028. The company beat first-quarter consensus on all metrics, with a net loss of $0.20 per share versus the expected $0.56 loss, though revenue of $516.87 million came in slightly light and second-quarter guidance reflected headwinds. Shares have delivered a 95% return over the past year, but the current report is more of a mixed-to-positive update than a major catalyst.

Analysis

SSP is increasingly a self-help story rather than a pure advertising beta: the market is beginning to price in EBITDA bridge delivery, not just cyclical recovery. That matters because the stock’s rerating can continue even if top-line growth stays mediocre, provided management keeps converting local sports and women’s sports into durable affiliate leverage and better mix. The key second-order effect is that improved execution may lower the company’s cost of capital, giving it more optionality on further deleveraging and asset rationalization than peers with weaker operating proof points.

The bigger beneficiary set is likely not other broadcasters, but content owners and sports-rights intermediaries that can package niche inventory at attractive economics. If SSP can prove that differentiated sports programming drives share without a national-scale rights war, smaller station groups may get a template for margin expansion without overbidding for major league content. The flip side is that competitors with heavier exposure to traditional linear advertising and weaker local sports positioning could be left with worse pricing power as SSP absorbs more of the “quality” perception in the group.

The main risk is timing mismatch: the equity can look cheap on medium-term EBITDA targets while near-term guidance is still vulnerable to carriage disputes, asset-sale noise, and a soft direct-response market. That creates a classic multi-quarter setup where the stock can rerate on every incremental operating proof point, but also retrace sharply if one or two bridges fail to close in the next 1-2 quarters. A longer-duration macro recovery in ad spend would help, but the cleaner catalyst is evidence that the transformation plan is becoming less dependent on one-off actions.

Consensus is probably underestimating how much of the valuation is now hostage to execution credibility rather than headline growth. If management keeps hitting milestones, the stock can grind higher even without a larger regulatory or M&A catalyst; if not, the market will likely de-rate the long-dated EBITDA claims quickly. In that sense, the asymmetry is better for trading around quarterly prints than for making an all-in strategic bet on a takeover that may remain blocked for months or years.

Key Decisions for Investors

• Go long SSP into the next earnings print or guidance update, with a 1-2 quarter horizon; the thesis is that incremental EBITDA proof can re-rate the multiple even if revenue remains choppy. Risk/reward is favorable as long as management continues to de-risk leverage and monetize niche sports inventory.
• Use a call spread in SSP rather than outright equity for the next 3-6 months; this captures rerating from execution while limiting downside if ad markets weaken or a carriage issue reappears.
• Pair SSP long against a weaker broadcast peer with less differentiated sports exposure over a 3-6 month window; the trade is designed to isolate execution and content-mix advantage rather than sector beta.
• If SSP rallies on confirmation of deleveraging progress, trim into strength rather than waiting for a policy/M&A catalyst; the stock’s upside is more likely to come in steps than in one clean revaluation.
• Avoid shorting SSP on valuation alone until at least one more quarter confirms that the transformation plan is slipping; the next negative catalyst likely needs operational disappointment, not just headline skepticism.